Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China · Delayed Price · Currency is CNY 11.25
+0.07 (0.63%)
Apr 30, 2026, 3:00 PM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 4.55 billion as of April 30, 2026. Its market cap has decreased by -13.85% in one year.
Market Cap
4.55B
Enterprise Value
4.95B
Revenue
1.68B
Ranking
n/a
PE Ratio
96.19
Stock Price
11.25
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 4.55B, an increase of 5.66%. That is a compound annual growth rate of 0.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.52B | -4.44% |
| Dec 31, 2025 | 4.74B | -9.02% |
| Dec 31, 2024 | 5.20B | -32.74% |
| Dec 29, 2023 | 7.74B | 37.27% |
| Dec 30, 2022 | 5.64B | -13.05% |
| Dec 31, 2021 | 6.48B | -21.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bide Pharmatech | 4.78B |
| Hunan Fangsheng Pharmaceutical | 4.74B |
| Yabao Pharmaceutical Group | 4.70B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 4.69B |
| Zhuhai Rundu Pharmaceutical | 4.62B |
| Tibet Weixinkang Medicine | 4.60B |
| Shandong Sinobioway Biomedicine | 4.53B |
| Jinling Pharmaceutical Company | 4.53B |